Perspective
Value-Based Pricing For Pharmaceuticals In The Trump Administration
April 27, 2017
Featured Experts: Darius Lakdawalla, PhD
Research
All Research Featured Research
Evidence Base
How Republicans and Democrats can Both Keep their Promises on Health Care
March 3, 2017
Featured Experts: Darius Lakdawalla, PhD
Evidence Base
Do You Know What The Affordable Care Act Does? Here’s A Primer To Help
March 2, 2017
Featured Experts: Darius Lakdawalla, PhD
Journal Article
MA14.09 Demonstrating Life Expectancy Gains with Immuno-Oncology (IO) Therapies
February 1, 2017
Featured Experts: Darius Lakdawalla, PhD
Journal Article
The Insurance Value of Medical Innovation
January 31, 2017
Featured Experts: Darius Lakdawalla, PhD
Journal Article
The Role of Imperfect Surrogate Endpoint Information in Drug Approval and Reimbursement Decisions
January 31, 2017
Featured Experts: Darius Lakdawalla, PhD, John Romley, PhD
Evidence Base
Why Academics Consulting with Industry on Health Care May be an Idea Whose Time has Come
December 21, 2016
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD
Journal Article
Physician Treatment Patterns: Evidence from Accountable Care Organizations
November 30, 2016
Featured Experts: Alice Chen, PhD, Darius Lakdawalla, PhD, Seth Seabury, PhD
Perspective
Election Verdict: Pharma Needs a New Prescription
November 14, 2016
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
Journal Article
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
June 30, 2016
Featured Experts: Seth Seabury, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Journal Article
Increasing Disability Decreases Employment Levels in Patients with Multiple Sclerosis
June 2, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Health, Body Weight, and Obesity
May 31, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Estimating the Lifetime Price of Pharmaceuticals: What Are the Long-Term Costs to Society?
May 31, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Does Patient Cost Sharing for HCV Drugs Make Sense?
May 3, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Value of Expanding HCV Screening and Treatment Policies in the United States
May 1, 2016
Featured Experts: Darius Lakdawalla, PhD, Karen Mulligan, PhD
Journal Article
The Wider Public Health Value of HCV Treatment Accrued by Liver Transplant Recipients
May 1, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Costs and Spillover Effects of Private Insurers’ Coverage of Hepatitis C Treatment
May 1, 2016
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Journal Article
NBER Working Paper: Prescription Drug Advertising and Drug Utilization – The Role of Medicare Part D
November 30, 2015
Featured Experts: Darius Lakdawalla, PhD, Neeraj Sood, PhD
News
What’s a Fair Price? The Debate Over Value & Cost of Specialty Drugs (Part 1)
September 24, 2015
Featured Experts: Darius Lakdawalla, PhD
Perspective
Moving Beyond Price-Per-Dose In The Pharmaceutical Industry
September 15, 2015
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD